10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2021 | |||
CONSOLIDATED STATEMENTS OF EARNINGS | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 9, 2022) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Total Revenues | $ 46,385 | 42,518 | 26,145 |
| Cost of products sold | 9,940 [1] | 11,773 | 8,078 |
| Marketing, selling and administrative | 7,690 | 7,661 | 4,871 |
| Research and development | 11,354 | 11,143 | 6,148 |
| IPRD charge - MyoKardia acquisition | 0 | 11,438 | 0 |
| Amortization of acquired intangible assets | 10,023 | 9,688 | 1,135 |
| Other (income)/expense, net | (720) | (2,314) | 938 |
| Total Expenses | 38,287 | 49,389 | 21,170 |
| Earnings/(Loss) Before Income Taxes | 8,098 | (6,871) | 4,975 |
| Provision for Income Taxes | 1,084 | 2,124 | 1,515 |
| Net Earnings/(Loss) | 7,014 | (8,995) | 3,460 |
| Noncontrolling Interest | 20 | 20 | 21 |
| Net Earnings(Loss) Attributable to BMS | 6,994 | (9,015) | 3,439 |
| Earnings per common share attributable to BMS, basic (in usd per share) | 3.15 | (3.99) | 2.02 |
| Earnings per common share attributable to BMS, diluted (in usd per share) | 3.12 | (3.99) | 2.01 |
| Principal Transaction Revenue, Description of Reporting Category | |||
| Net product sales | |||
| Total Revenues | 45,055 | 41,321 | 25,174 |
| Alliance and other revenues | |||
| Total Revenues | 1,330 | 1,197 | 971 |
| [1] Excludes amortization of acquired intangible assets. | |||
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |